|0.81||-0.0199 / -2.40%|
Data as of 3:59pm ET
|0.8279||+0.0179 / +2.21%|
The 2 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +146.91% increase from the last price of 0.81.
The current consensus among 2 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.